Latest News

Filters close
27-Jul-2020 4:00 PM EDT
American Association for the Study of Liver Diseases Foundation Announces Funding of over $2.2 Million in Research and Career Development Awards, Abstract Awards, and Emerging Liver Scholars Program
American Association for the Study of Liver Diseases (AASLD)

The American Association for the Study of Liver Diseases (AASLD) Foundation, the largest private supporter of liver disease research and training in the United States, today announced its combined investment of over $2.2 million in Research and Career Development Awards, Abstract Awards, and its Emerging Liver Scholars (ELS) Program.

Released: 25-Mar-2020 1:15 PM EDT
AASLD Releases Clinical Insight Guide for Treating Patients with Liver Disease and COVID-19
American Association for the Study of Liver Diseases (AASLD)

The American Association for the Study of Liver Disease (AASLD) has released a clinical insight document for clinicians and frontline healthcare providers who are treating patients with liver disease during the COVID-19 pandemic. The document, which cites recent studies conducted in China, assesses how hepatologists and liver transplant physicians/surgeons and their patients may be affected by the COVID-19 virus (also known as SARS-CoV-2) and provides continued guidance on clinical approaches to disease management.

Released: 3-Dec-2019 3:40 PM EST
HCV Guidance Updates Recommendations for Identification and Management of Chronic Hep C
American Association for the Study of Liver Diseases (AASLD)

HCVguidelines.org — a website developed by the American Association for the Study of Liver Diseases and the Infectious Diseases Society of America to provide up-to-date guidance on the management of hepatitis C — was recently revised to reflect important developments in the identification and management of chronic hepatitis C (HCV)

Released: 20-Nov-2019 3:30 PM EST
Matthew R. D’Uva to Join AASLD as CEO
American Association for the Study of Liver Diseases (AASLD)

The American Association for the Study of Liver Diseases (AASLD) has appointed Matthew R. D’Uva, FASAE, CAE, as its new chief executive officer, effective January 21, 2020.

4-Nov-2019 8:00 AM EST
Pregnant Women With Cirrhosis Have Low Levels of Liver Decompensation Within a Year of Delivery
American Association for the Study of Liver Diseases (AASLD)

Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases and funded by the AASLD Foundation

4-Nov-2019 8:00 AM EST
Innovative Machine Learning Tool Predicts Who Might Have Non-Alcoholic Steatohepatitis
American Association for the Study of Liver Diseases (AASLD)

Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that a machine-learning tool could successfully predict the risk of having non-alcoholic steatohepatitis (NASH) among patients with co-existing diseases.

4-Nov-2019 8:00 AM EST
NAFLD Patients Less Likely to Lose Weight, Need More Effective Weight Loss Strategies
American Association for the Study of Liver Diseases (AASLD)

Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that obese individuals with nonalcoholic fatty liver disease (NAFLD) were less likely to achieve a medically recommended five percent loss of body weight at three months

Newswise: All-Oral Direct-Acting Antiviral Treatments Improve 
Survival in Patients with HCV-Related Hepatocellular Carcinoma
4-Nov-2019 8:00 AM EST
All-Oral Direct-Acting Antiviral Treatments Improve Survival in Patients with HCV-Related Hepatocellular Carcinoma
American Association for the Study of Liver Diseases (AASLD)

Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that hepatitis C virus-related hepatocellular carcinoma (HCC) patients who achieved sustained virologic response (SVR) – denoting an undetectable level of HCV virus - with any oral direct-acting antiviral (DAA) had over 60-70 percent improvement in five-year survival.

Newswise: A Healthy Lifestyle May Help Prevent Liver-Related Deaths
4-Nov-2019 8:00 AM EST
A Healthy Lifestyle May Help Prevent Liver-Related Deaths
American Association for the Study of Liver Diseases (AASLD)

Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that a substantial burden of hepatocellular carcinoma (HCC) and cirrhosis-related deaths may be prevented by lifestyle modifications to diet, alcohol use and exercise.

4-Nov-2019 8:00 AM EST
Global Hepatology Societies Call for Better HCV Testing and Access to Treatment
American Association for the Study of Liver Diseases (AASLD)

Four societies focused on liver disease research and treatment announced a global call-to-action initiative to simplify hepatitis C testing and treatment.

4-Nov-2019 8:00 AM EST
Kratom, Botanical Supplement with Opioid-Like Activity, May Cause Liver Toxicity and Injury
American Association for the Study of Liver Diseases (AASLD)

Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that kratom, a popular and widely available product, may cause liver toxicity and severe liver injury.

4-Nov-2019 8:00 AM EST
U.S. Cirrhosis Patients Often Skip or Delay Liver Cancer Surveillance Due to Cost and Lack of Insurance
American Association for the Study of Liver Diseases (AASLD)

Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that cirrhosis patients in the U.S. have substantial financial burden

4-Nov-2019 8:00 AM EST
Sexual Transmission of Hepatitis C Low Among HIV-Negative Men Who Have Sex with Men on PrEP
American Association for the Study of Liver Diseases (AASLD)

Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found fewer new cases of hepatitis C infection (commonly called HCV), despite very high rates of other sexually-transmitted infections, in HIV-negative men who have sex with men who take pre-exposure prophylaxis (PrEP) treatments.

4-Nov-2019 8:00 AM EST
Could Combining Direct-Acting Antivirals with a Common Cholesterol Medication Open the Door to More Viable Organs for Transplantation?
American Association for the Study of Liver Diseases (AASLD)

Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that combination therapy with direct-acting antivirals (DAAs) and ezetimibe

Released: 24-Jun-2019 4:30 PM EDT
AASLD Foundation Invests $3.42 Million in Liver Disease Research and Career Development
American Association for the Study of Liver Diseases (AASLD)

The American Association for the Study of Liver Diseases Foundation, the largest private supporter of liver disease research and training in the United States, today announced its investment of $3.42 million in Research and Career Development Awards granted to 29 researchers and clinicians to conduct innovative liver disease research and seek advanced hepatology training.

2-Nov-2018 2:30 PM EDT
Weight-Loss Surgery Effectively Reduces Weight and Lowers Risk of Post- Liver Transplant Complications in Obese Patients
American Association for the Study of Liver Diseases (AASLD)

SAN FRANCISCO – Preliminary data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that weight-loss surgery prior to liver transplantation is superior to medical weight loss approaches at achieving sustained weight loss, as well as significantly lowering risk of metabolic complications after transplant.

2-Nov-2018 2:30 PM EDT
Clinically Significant Liver Toxicity Related to Anti-Cancer Drugs is Rare but Often Leads to Discontinuation of Treatment
American Association for the Study of Liver Diseases (AASLD)

SAN FRANCISCO – Preliminary data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that patients treated with immune checkpoint inhibitors rarely develop severe liver toxicity, but the majority of those who do permanently stop this cancer treatment. None of the patients developed liver failure as a result of this treatment.

2-Nov-2018 2:30 PM EDT
Liver Cancer Combined with Other Liver Diseases Driving Higher Death Rate and Health Care Costs for U.S. Seniors
American Association for the Study of Liver Diseases (AASLD)

SAN FRANCISCO – Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that hospitalizations and death are increasing among Medicare recipients with hepatocellular carcinoma, mainly due to co-existing alcoholic liver disease, hepatitis C virus infection (commonly called HCV) and nonalcoholic fatty liver disease (commonly called NAFLD).

2-Nov-2018 2:30 PM EDT
People with Hepatitis C Who Actively Inject Illegal Drugs Have High Rates of Hepatitis C Treatment Adherence and Cure
American Association for the Study of Liver Diseases (AASLD)

SAN FRANCISCO – Preliminary data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that people who inject drugs who are infected with the hepatitis C virus have high rates of hepatitis C treatment adherence (completion of their treatment), and sustained virologic response. Based on these findings, researchers conclude these patients should be included in HCV treatment programs.

2-Nov-2018 2:30 PM EDT
African-Americans Face Significant Delays in Liver Transplantation Despite High Priority Scores
American Association for the Study of Liver Diseases (AASLD)

SAN FRANCISCO – Preliminary data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that African-American patients on waitlists for liver transplantation, despite severe disease and high scores for prioritization, persistently face significant disparities and delays in referral.

2-Nov-2018 2:30 PM EDT
Combined Glecaprevir and Pibrentasvir Found Highly Effective in Chronic Hepatitis C Patients Who Have Failed Other Therapies
American Association for the Study of Liver Diseases (AASLD)

SAN FRANCISCO – Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found the combination of glecaprevir and pibrentasvir is highly effective and well tolerated in patients with chronic hepatitis C virus (commonly called HCV) genotype-1 infections who have prior treatment experience with sofosbuvir/NS5A inhibitor.

2-Nov-2018 2:30 PM EDT
Universal Hepatitis C Screening of Pregnant Women More Cost-Effective Than Risk-Based Approach
American Association for the Study of Liver Diseases (AASLD)

SAN FRANCISCO – Preliminary data from a new study presented this week at The Liver Meeting® – held by The American Association for the Study of Liver Diseases – found that universal screening of pregnant women at risk for hepatitis C virus (commonly called HCV) infection is a more efficient and cost-effective diagnostic approach than risk-based screening.

2-Nov-2018 2:30 PM EDT
Nonalcoholic Fatty Liver Disease Patients Have Higher Rates of All Non-Liver-Related Cancers
American Association for the Study of Liver Diseases (AASLD)

SAN FRANCISCO – Preliminary data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that rates of malignancy occurring outside of the liver were higher in adults with nonalcoholic fatty liver disease than among adults across most types of cancers.

2-Nov-2018 2:30 PM EDT
Normothermic Machine Perfusion Can Salvage Fatty Livers for Transplantation
American Association for the Study of Liver Diseases (AASLD)

SAN FRANCISCO – Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that using normothermic machine perfusion to preserve steatotic livers leads to altered lipid structure and metabolism and may result in more successful transplantation of these organs.

2-Nov-2018 2:30 PM EDT
Preemptive Antiviral Therapy Prevents Chronic Hepatitis C Infection in Heart Transplant Patients Who Receive Infected Donor Organs
American Association for the Study of Liver Diseases (AASLD)

SAN FRANCISCO – Preliminary data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that pre-emptive administration of pan-genotypic, direct-acting antiviral therapy prevents chronic hepatitis C virus infection in hepatitis C-negative cardiac transplant patients who receive donor hearts infected with the virus.

2-Nov-2018 2:30 PM EDT
Under-Immunization Still a Major Problem in Pediatric Liver Transplant Patient Population
American Association for the Study of Liver Diseases (AASLD)

SAN FRANCISCO – Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that more than half of pediatric liver transplant recipients are under-immunized at the time of their transplant and are at increased risk for vaccine-preventable infections.

2-Nov-2018 2:30 PM EDT
Five Years of Regular Aspirin Use Helps Prevent Common Liver Cancer
American Association for the Study of Liver Diseases (AASLD)

SAN FRANCISCO – Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that taking a regular aspirin is associated with a dose-dependent reduction in the risk of hepatocellular carcinoma, one of the most common liver cancers. The cancer risk reduction is apparent after at least five years of aspirin use, the study showed.

18-Oct-2017 12:00 AM EDT
Screening for Hepatitis C Improves Opioid Abuse Treatment Outcomes
American Association for the Study of Liver Diseases (AASLD)

Research presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – shows people in treatment for opioid substance abuse significantly lowered their non‐prescribed opioid use after testing positive for hepatitis C virus.

18-Oct-2017 12:00 AM EDT
The Increasing Cost of Alcohol Abuse
American Association for the Study of Liver Diseases (AASLD)

Health care costs for privately insured patients with alcoholic cirrhosis are nearly twice that of non‐alcoholic cirrhosis patients in the United States, according to research presented this week at The Liver Meeting® — held by the American Association for the Study of Liver Diseases.

18-Oct-2017 12:00 AM EDT
Can You Inherit a Fatty Liver?
American Association for the Study of Liver Diseases (AASLD)

Serum metabolites associated with nonalcoholic fatty liver disease may be heritable, according to research presented this week at The Liver Meeting® — held by the American Association for the Study of Liver Diseases.

18-Oct-2017 12:00 AM EDT
Direct‐Acting Antiviral Therapy Cuts Liver Cancer Risk By 71%
American Association for the Study of Liver Diseases (AASLD)

A new study presented this week at The Liver Meeting® — held by the American Association for the Study of Liver Diseases — found that eradication of the hepatitis C virus induced by direct‐acting antiviral medications is associated with a 71 percent reduction in the risk of liver cancer.

18-Oct-2017 12:00 AM EDT
The Frequency of Herbal and Dietary Supplement Mislabeling
American Association for the Study of Liver Diseases (AASLD)

Herbal and dietary supplement mislabeling is common and should be evaluated as a potential cause for liver damage, according to research presented this week at The Liver Meeting® — held by the American Association for the Study of Liver Diseases.

18-Oct-2017 12:00 AM EDT
Deaths Rates of Liver Cirrhosis Exceed Those of 5 Major Cancers
American Association for the Study of Liver Diseases (AASLD)

A new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that liver cirrhosis mortality is greater than that of five major cancers, implying the development of appropriate interventions to treat or prevent liver cirrhosis must be prioritized.

18-Oct-2017 12:00 AM EDT
Pregnancy Rates on the Rise Among Women with Chronic Liver Disease
American Association for the Study of Liver Diseases (AASLD)

A new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that the overall number of pregnancies in women with chronic liver disease or following liver transplantation has risen over the past 30 years. In addition, the proportion of full‐term pregnancies has increased significantly over that time period, and most women had favorable pregnancy outcomes.

18-Oct-2017 12:00 AM EDT
Use of Hepatitis C Positive Liver Organs
American Association for the Study of Liver Diseases (AASLD)

Use of liver organs from selected hepatitis C positive donors should be considered due to modest risk of hepatitis C transmission and the availability of safe and effective direct‐acting antiviral therapies, according to research presented this week at The Liver Meeting® — held by the American Association for the Study of Liver Diseases.

18-Oct-2017 12:00 AM EDT
Can an Aspirin a Day Keep Liver Cancer Away?
American Association for the Study of Liver Diseases (AASLD)

A new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that daily aspirin therapy was significantly associated with a reduced risk in hepatitis B virus‐related liver cancer.

18-Oct-2017 12:00 AM EDT
One Liver. Two Saved Lives
American Association for the Study of Liver Diseases (AASLD)

A new study presented this week at The Liver Meeting® — held by the American Association for the Study of Liver Diseases — found that increased utilization of split liver transplantation (sharing a donor liver between one pediatric and one adult patient) could decrease the number of children who die awaiting liver transplantation without decreasing liver transplantation access for adult patients.

18-Oct-2017 12:00 AM EDT
Cardiovascular Risk in Women with Fatty Liver Disease: Risk is Not Equal Opportunity
American Association for the Study of Liver Diseases (AASLD)

Nonalcoholic fatty liver disease is associated with significantly higher risk of subsequent cardiovascular events in women, but not in men, according to research presented this week at The Liver Meeting® — held by the American Association for the Study of Liver Diseases.


Showing results

138 of 38

close
0.94756